FDA
-
-
-
-
-
-
-
NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
-
-
-
-
-
-
-
NeuroSense reports 65% death risk reduction in ALS trial
-
-
-
-
-
326,553 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

